Associate Director, HEOR, Hematology, Europe and Markets

Associate Director, HEOR, Hematology, Europe and New Markets

Take a key role in shaping HEOR evidence strategy across a global hematology portfolio, supporting European HTA and JCA readiness across Europe and New Markets.

• Support the development and delivery of HEOR strategies and evidence‑generation activities across hematology assets in Europe and New Markets.
• Partner with Market Access, Medical Affairs, Clinical Development, Biostatistics and Global teams to identify evidence gaps and prioritize HEOR activities based on regional and country needs.
• Develop and execute evidence‑generation projects, including comparative effectiveness research, real‑world evidence and health economic analyses.
• Contribute to European HTA and EU Joint Clinical Assessment (JCA) evidence strategy and readiness.
• Support JCA PICO strategy and planning, including assessment of relevant populations, subgroups, comparators and outcomes, identification of evidence gaps and evaluation of potential evidence‑generation approaches.
• Lead or support comparative evidence generation for JCA and other HTA requirements.
• Develop and critically review study protocols, analysis plans, reports, publications and other HEOR deliverables, ensuring scientific and methodological quality.
• Evaluate clinical trial, external and real‑world data together with internal experts and external partners to determine the most appropriate approaches for addressing evidence gaps.
• Manage external HEOR vendors and projects, including scope definition, methodological review, timelines, deliverables and quality control.
• Support the interpretation and communication of HEOR evidence, including assumptions, uncertainty, limitations and implications for HTA and evidence strategy.

Our client is a global, science‑led biopharmaceutical company focused on oncology, with a strong international footprint and a commitment to accelerating the development of and access to innovative cancer medicines. With hematology as a core area of research and development, the organization combines global capabilities with a fast‑moving, collaborative culture and a strong focus on generating meaningful impact for patients.

• A Master’s degree or PhD in Health Economics, Outcomes Research, Epidemiology, Public Health, Statistics or a related discipline.
• At least 5 years of relevant experience in HEOR, HTA, real‑world evidence or comparative effectiveness research, ideally gained within the pharmaceutical/biotech industry or consulting.
• A strong understanding of European HTA and evidence requirements
  ; knowledge of or experience with the EU HTA Regulation and Joint Clinical Assessment (JCA) is a strong advantage.
• Experience with comparative effectiveness methodologies such as ITC/NMA and, ideally, population‑adjusted approaches including MAIC/STC
  .
• Hands‑on experience designing, managing and critically reviewing HEOR studies and collaborating with external research vendors.
• Experience or knowledge within hematology and/or oncology would be an advantage.
• Strong analytical and critical‑thinking skills, with the ability to translate evidence gaps into actionable research activities.
• The ability to work effectively across functions and geographies while managing multiple projects and changing priorities.
• Excellent written and verbal communication skills in English.
• A proactive, highly organized and independent working style suited to a dynamic, fast‑paced environment.

Swisslinx AG Löwenstrasse 29 8001 Zürich